Company: BIAF
Filing Date: 2025-05-07
Form Type: 424B4
Source: 0001641172-25-008977
Chunk: 168

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-07
Form: 424B4
Chunk 168
---
 subject to voluntary adjustment. The May 2025 Warrants will be issued in certificated form only.

The terms of the May 2025 Warrants will also include (i) a one-time thirty percent increase in the number of shares of Common Stock issuable upon exercise of the May 2025 Warrants if a reverse stock split is effected prior to the expiration of the May 2025 Warrants and (ii) subject to Warrant Stockholder Approval, a decrease of the exercise price of the May 2025 Warrants, if in a subsequent offering of our securities the price paid for Common Stock, the exercise price of any options or warrants or the conversion price of any convertible securities issued in such subsequent offering is less than the exercise price immediately prior to such subsequent offering (a “Dilutive Issuance”), to an exercise price that is equal to the lowest of the price paid for Common Stock, the exercise price of any options or warrants or the conversion price of any convertible securities issued in such subsequent offering (subject to a floor of $0.10 per share) and an increase in the number of shares of our Common Stock underlying the May 2025 Warrants so that the reset exercise price multiplied by the increased number of shares equals the aggregate proceeds that would have resulted from the full exercise of the May 2025 Warrants immediately prior to the reset (the “Anti-Dilution Adjustment”). We have agreed not to consummate a subsequent Dilutive Issuance until the earlier of (i) eight months from the closing date of this offering and (ii) later of: (a) the filing of a registration statement registering the resale of the shares issuable as a result of an Anti-Dilution Adjustment, which registration statement we agree to use our commercially reasonable efforts to become effective; (b) the Stockholder Approval Notice Date; and (c) the effective date of the filingof the Certificate of Amendment. If a reverse stock split is effected an additional 4,570,312 (on a pre-reverse split basis which number shall be adjusted based on the reverse stock split ratio) shares of Common Stock will be issuable upon exercise of the May 2025 Warrants and then, subject to obtaining Warrant Stockholder Approval, if a subsequent offering occurs for which the exercise price of the May 2025 Warrants is reset to the floor price of $0.10 per share, an additional 49,907,811 (on a pre-reverse split basis which number shall be adjusted